BioCatalyst

MIRM — Mirum Pharmaceuticals, Inc. catalysts

2 verified catalyst event(s) for Mirum Pharmaceuticals, Inc. (ticker MIRM). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic
Phase 3 · Chronic Hepatitis D Infection
 MIRM Mirum Pharmaceuticals, Inc. Brelovitug 300 mg, Brelovitug 900 mg, De ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-10 (month)
in 3mo
ESTIMATED
 READOUT
Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver
Phase 3 · Cholestatic Liver Disease (Except ALGS, PFIC, PBC and PSC)
 MIRM Mirum Pharmaceuticals, Inc. Maralixibat ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.